China Dasheng Biotechnology Company
CDBT · OTC
12/31/2024 | 9/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $0 | $0 | $2 |
| Short-Term Investments | $109 | $123 | $116 | $120 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $112 | $123 | $116 | $122 |
| Property Plant & Equip (Net) | $92 | $102 | $106 | $106 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $216 | $242 | $228 | $238 |
| Total NC Assets | $308 | $344 | $333 | $343 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $420 | $467 | $449 | $465 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $1,099 | $1,201 | $1,279 | $1,287 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $37 | $42 | $39 | $41 |
| Other Curr. Liab. | $39 | $40 | $767 | $696 |
| Total Curr. Liab. | $1,176 | $1,283 | $2,085 | $2,024 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,176 | $1,283 | $2,085 | $2,024 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $1 | $1 |
| Common Stock | $41 | $41 | $41 | $41 |
| Retained Earnings | -$1,851 | -$1,817 | -$1,910 | -$1,803 |
| AOCI | $19,111 | $19,018 | $19,063 | $19,034 |
| Other Equity | -$18,058 | -$18,058 | -$18,831 | -$18,831 |
| Total Equity | -$756 | -$815 | -$1,636 | -$1,558 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $420 | $467 | $449 | $465 |
| Net Debt | $1,096 | $1,201 | $1,279 | $1,285 |